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Automated quantification 
of posterior vitreous inflammation: 
optical coherence tomography scan 
number requirements
Jan Henrik Terheyden 1*, Giovanni Ometto2, Giovanni Montesano2, 
Maximilian W. M. Wintergerst 1, Magdalena Langner1, Xiaoxuan Liu 3,4, Pearse A. Keane 5, 
David P. Crabb 2, Alastair K. Denniston 3,4,5 & Robert P. Finger1*
Quantifying intraocular inflammation is crucial in managing uveitis patients. We assessed the 
minimum B-scan density for reliable automated vitreous intensity (VI) assessment, using a novel 
approach based on optical coherence tomography (OCT). OCT volume scans centered on the macula 
were retrospectively collected in patients with uveitis. Nine B-scans per volume scan at fixed locations 
were automatically analyzed. The following B-scan selections were compared against the average 
score of 9 B-scans per volume scan as a reference standard: 1/3/5/7 central scans (1c/3c/5c/7c), 3 
widely distributed scans (3w). Image data of 49 patients (31 females) were included. The median 
VI was 0.029 (IQR: 0.032). The intra-class-correlation coefficient of the VI across the 9 B-scans was 
0.923. The median difference from the reference standard ranged between 0.001 (7c) and 0.006 (1c). 
It was significantly lower for scan selection 3w than 5c, p(adjusted) = 0.022, and lower for selection 
7c than 3w, p(adjusted) = 0.003. The scan selections 7c and 3w showed the two highest areas under 
the receiver operating curve (0.985 and 0.965, respectively). Three widely distributed B-scans are 
sufficient to quantify VI reliably. Highest reliability was achieved using 7 central B-scans. Automated 
quantification of VI in uveitis is reliable and requires only few OCT B-scans.
Uveitis is a common inflammatory disease of the eye, accounting for 5–10% of visual impairment  worldwide1,2. 
The disease affects the vascular layer (consisting of iris, ciliary body and choroid) of people who are frequently of 
working  age1,3. Quantification of intraocular inflammation is crucial in managing patients with uveitis. To date 
the quantification of intraocular inflammation is mostly done semi-quantitatively by subjective clinical evalu-
ation, which comes with a range of limitations common to subjective  ratings3–5. Thus, several approaches have 
been developed to quantify vitreous intensity (VI) more  objectively6–9. This includes quantification of vitreous 
inflammation based on optical coherence tomography (OCT)  scans8–12.
The developed algorithm for an automatic assessment of vitreous inflammation is based on the measurement 
of hyperreflective spots within the posterior vitreous included on macular OCT scans. As this parameter alone is 
prone to artefacts due to media opacities, a score relative to the retinal pigment epithelium has been established 
in previous studies and evaluated against the reference standard of the Standardization of Uveitis Nomenclature 
(SUN) clinical grading of vitreous  haze8–13.
The application of an OCT-based, automated algorithm for quantification of vitreous inflammation requires 
manual selection and a certain amount of manual post-processing steps of scans. For this reason, the number 
of scans should be limited to the minimum amount required for reliable quantification of VI to facilitate future 
employment in clinical routine and randomized controlled clinical trials. These applications include a potential 
use of the OCT-based parameter as a biomarker for therapeutic decisions, follow-up intervals and as a clinical 
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trial endpoint. Thus, we assessed the minimum required number of B-scans to reliably quantify vitreous inflam-
mation in this study.
Results
Current image data of 49 eyes of 49 patients (31 females, 18 males) examined at a tertiary referral centre were 
included. Uveitis was classified as intermediate in 8 eyes, posterior in 33 eyes and panuveitis in 8 eyes. Mean age at 
examination was 70 ± 12 years; mean logMAR BCVA at examination was 0.5 ± 0.3 and 44 eyes were pseudophakic.
The mean distance between two B-scans was 243 ± 8 µm (Fig. 1, individual B-scans are represented by green 
lines). Across all B-scans, the median VI was 0.029 (interquartile range: 0.032), ranging from 0.0026 to 0.394. The 
mean VI per eye did not differ significantly between phakic and pseudophakic eyes (P = 0.919). The intra-class 
correlation coefficient of the VI values across the 9 B-scans was 0.923 (95% confidence interval 0.886 – 0.952), 
indicating high agreement between VI values.
Smaller median differences indicate less variation from the chosen reference standard (i.e. the mean VI value 
from 9 B-scans, Fig. 1). Table 1 shows that the median differences between the reference standard and the aver-
age values of scan selections (1 central scan, 1c; 3 central scans, 3c; 5 central scans, 5c; 7 central scans, 7c and 3 
widely distributed scans, 3w) were noticeably different. For instance, the difference from the total VI average in 
Figure 1.  Illustration of an infrared image linked to an OCT volume scan that consists of 19 B-scans. The white 
dots indicate which scans (green lines) have been included in the different sub selections of B-scans (columns).
Table 1.  Deviation between the reference standard (VI means of 9 B-scans) and average VI values from the 
sub selections of B-scans and respective limits of agreement. VI, vitreous intensity.
Scan sub selection
Median VI difference from reference standard 
(interquartile range) Limits of agreement compared to reference standard
1 central scan (1c) 0.006 (0.009) [− 0.039;0.037]
3 central scans (3c) 0.005 (0.011) [− 0.033;0.032]
5 central scans (5c) 0.004 (0.009) [− 0.028;0.026]
7 central scans (7c) 0.001 (0.004) [− 0.009;0.009]
3 wide scans (3w) 0.003 (0.005) [− 0.014;0.013]
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9 B-scans was smaller in the sub selection 3w compared to 5c (Holm-Bonferroni adjusted P = 0.022). It was also 
smaller in the sub selection 7c compared to 3w (Holm-Bonferroni adjusted P = 0.003).
Linear regression analysis revealed no significant associations between the two axes on Bland–Altman plots 
with each other, comparing the reference standard with the VI scores from individual scan selections (compara-
tors: 1c, p = 0.907; 3c, p = 0.120; 5c, p = 0.172; 7c, p = 0.604; 3w, p = 0.243).
All area under the curve (AUC) values from ROC analysis were > 0.8 (Table 2), indicating high sensitivity 
and specificity for the detection of values larger than the dataset’s median, i.e. detection of eyes with statistically 
“higher inflammation” in contrast to eyes with “lower inflammation”. The scan sub selections 7c and 3w achieved 
the highest sensitivity and specificity values (Fig. 2). We achieved similar results using a comparison with the 
dataset’s upper and lower quartile as state variables (data not shown).
Discussion
The results indicate that Vitreous/RPE-relative intensity is consistent across OCT scans in individuals with 
uveitis. Averaging the VI of several B-scans within one OCT volume scan further improved measurement reli-
ability because it reduces the influence of local structural alterations. VI calculation from three widely distributed 
B-scans (average distance 1944 µm) achieves comparable results with VI calculation from nine equally distributed 
B-Scans (average distance 486 µm) and allows for sufficient discrimination of different levels of inflammation.
Our results indicate that less dense scan patterns compare well to more dense scans in the quantification of 
VI. As the biomarker itself as well as the measurement of vitreous inflammation using OCT are relatively novel, 
no data comparing different scan densities for this purpose are available so far. However, different OCT scan 
patterns of the macula have been compared in the literature with respect to detection of retinal biomarkers such 
as the presence of intraretinal fluid and quantification of retinal layer thicknesses. Sayanagi and colleagues did 
not find a significant difference in retinal thickness measurements of patients with macular diseases between a 
dense OCT volume scan and a radial scan consisting of 6  lines14. Other groups confirmed that retinal thickness 
can be measured almost as reliably with low B-scan density scans compared to high density scans in individuals 
with defined macular diseases such as diabetic macular  oedema15,16, age-related macular  degeneration17 and 
retinal vein  occlusion18. Different studies showed the detection of fluid to be almost as sensitive in scan patterns 
Table 2.  Area under the curve values for the detection of values larger than the dataset’s median, per scan sub 
selection. AUC, area under the curve; CI, confidence interval.
Scan sub selection AUC [95% CI]
1 central scan (1c) 0.862 [0.753; 0.971]
3 central scans (3c) 0.870 [0.767; 0.974]
5 central scans (5c) 0.929 [0.855; 1.0]
7 central scans (7c) 0.985 [0.954; 1.0]
3 wide scans (3w) 0.965 [0.912:.1.0]
Figure 2.  Receiver operating curves of the different scan sub selections. The state variable was the dataset’s 
median. 1c, 1 central scan; 3c, 3 central scans; 5c, 5 central scans; 7c, 7 central scans; 3w, 3 wide scans.
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only 25–50% as dense as the respective reference standard in age-related macular degeneration, diabetic macular 
oedema, retinal vein occlusion and other retinal  diseases17–23.
Our main result that a pattern with a smaller number of OCT B-scans-based measurements is similarly 
sensitive as a denser reference standard is thus consistent with findings reported in the literature. The scan sub 
selection “3w” including a central B-scan and two peripheral B-scans was superior to a single central scan, 3 
central scans and 5 central scans. Reliability can be increased with 7 B-scans, i.e. the difference from the refer-
ence standard was significantly lower, but the relevance of this small decrease in mean difference is unclear and 
needs to be considered against the increased workload.
Of note is that the minimum scan density that can be recommended for the measurement of VI is lower 
than the one recommended for use in retinal diseases to assess retinal thickness or presence of macular oedema 
reported in the literature. The minimum number of B-scans required for these purposes varies between five 
and 32  scans17–23. The diffuse nature of the signal in the vitreous cavity in inflammatory diseases in contrast to 
clearly locatable pathologies in only a small part of the retina in retinal diseases might be a potential explana-
tion for this. However, the impact of local heterogeneity in vitreous haze or accumulation of inflammatory cells 
(e.g. snowballs) on the OCT-based parameter and its changes with eye movement require further investigation.
The strengths of our study include a standardized imaging protocol for all participants, a relatively homog-
enous sample consisting of only uveitis patients (excluding anterior uveitis) and the use of a previously developed 
algorithm which is already clinically validated. Limitations include the relatively small sample size with only a 
limited number of B-scans per subject available, the use of only one device (Spectralis, Heidelberg Engineering), 
the relatively high age of the participants for a uveitis population, and the limited availability of clinical data. 
In this study we have considered measurements taken at a single visit, and therefore have not considered the 
stability of the signal over time.
Overall, our study shows that automated determination of VI is reliable across OCT B-scans in uveitis 
patients. The recommended minimum B-scan density for future research based on this parameter is three hori-
zontal scans: One central scan and two peripheral scans located approximately 2000 µm inferiorly and superiorly 
from the central B-scan (3w). Measurements were even more stable across scans in a pattern of 7 horizontal 
scans (7c) but we interpret this improvement as not clinically relevant compared to the recommended pattern. 
In the future, further correlation of the data with clinical vitreous haze scores and other clinical variables as well 
as further reliability analysis based on these values is warranted.
Methods
The retrospective study took place at the department of ophthalmology of the University of Bonn, Germany. 
The institutional Ethics Committee (University Hospital Bonn, Germany) approved the use of retrospective data 
for study purposes and approved that informed consent can be waived due to the use of retrospective data only 
(no. 103/18). The study adhered to the principles of the declaration of Helsinki. Participants were included if 
they had a form of Posterior Segment Involving Uveitis (PSIU) i.e. one of Intermediate, posterior or panuveitis 
as classified according to the SUN  criteria3.
Image data. Macular OCT volume scans were retrospectively collected. OCT is a light-based, non-invasive 
technique frequently applied in ophthalmology. It is based on local interference between two signals (object sig-
nal and reference signal)24,25. Using software, B-scans (e.g. axial) are automatically calculated from A-scans. Reti-
nal OCT B- scans show parts of the posterior vitreous cavity, the retinal layers as well as choroidal structures. The 
volume scans were obtained with the Spectralis SD-OCT (Heidelberg Engineering, Heidelberg, Germany), with 
a B-scan image resolution of 512 × 496 pixels and 5 images averaged (automated real-time tracking mode = 5). 
Inclusion criteria were volume scans consisting of 19 B-scans each and a B-scan size of 20° × 15°. Exclusion cri-
teria were insufficient image quality (HEYEX software image quality score < 20 in > 3 B-scans), incomplete scan, 
fixation errors and a presumed disease aetiology other than uveitis. Besides image data, age, uveitis classification, 
best-corrected visual acuity (BCVA) and lens status of all included patients were collected.
Image analysis. Every other B-scan was selected from the OCT volume scans, resulting in 9 B-scans per 
volume scan available for analysis (Fig.  1). As one of the previous VI algorithm validation studies included 
a reference of 7 B-scans per volume, we used a comparable density as our gold  standard11. The image data 
and additional image acquisition parameters were imported into MATLAB, Version R2016a (The MathWorks, 
Natick, Massachusetts, USA). The VI parameter Vitreous/Retinal Pigment Epithelium (RPE)-relative intensity 
was automatically calculated per B-scan according to an algorithm that has previously been described and clini-
cally  validated8–12,26. In summary, pre-processing steps include opening, thresholding and adjustment as out-
lined by Keane et al.9. The posterior part of the vitreous cavity is automatically detected and the OCT sum signal 
in this area is quantified relative to the RPE signal intensity in order to lower the impact of media opacities on the 
outcome parameter. The overall vitreous reflectivity is increased in inflammation which has been explained e.g. 
by inflammatory components and proteins in the vitreous  cavity9,26. B-scan quality was assessed for all selected 
B-scans and the distance between B-scans was obtained per individual volume scan.
Statistical analyses. The intra-class correlation coefficient between all VI values per volume scan was cal-
culated. The single VI value of the central B-scan (1c) and averaged VI values of five combinations of B-scans (3, 
5 and 7 central scans (3c, 5c, 7c), all 9 scans available for analysis (9 s), 3 widely distributed scans (3w); Fig. 1) 
were computed for all volume scans included. The averaged VI value of 9 B-scans was used as the standard refer-
ence. Mean absolute differences between this reference and a single central B-scan VI as well as the averaged VI 
values listed above (3c, 5c, 7c, 3w) were calculated. 95% limits of agreement (LoA) were calculated according to 
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the formula LoA = mean ± 1.96 × standard deviation of the differences between the two measurements. Linear 
regression analysis was performed based on Bland–Altman plots to identify associations between the above 
mentioned mean absolute differences (e.g. 9 s-1c, 9 s-3c, 9 s-5c, etc.) and their respective means, excluding four 
cases that were likely outside of the sensitivity range of our study (mean VI score > 0.1). In addition, we per-
formed receiver operating curve characteristic (ROC) analysis for discrimination of VI values greater or equal 
and VI values smaller than the median VI value out of all B-scans.
Statistical analyses were performed with SPSS Statistics, version 25 (IBM Corporation, Armonk, New York, 
USA) and R, version 3.5.0 (R Core Team, Vienna, Austria). Paired samples were compared with the Wilcoxon 
rank sum test correcting for multiple comparisons using the Holm-Bonferroni  method27. The level of statistical 
significance was P < 0.05.
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